Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1992;86:1495-1500

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rangemark, C.
Right arrow Articles by Wennmalm, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rangemark, C.
Right arrow Articles by Wennmalm, A.

Circulation, Vol 86, 1495-1500, Copyright © 1992 by American Heart Association


ARTICLES

Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age

C Rangemark, G Benthin, EF Granstrom, L Persson, S Winell and A Wennmalm
Department of Clinical Physiology, Gothenburg University, Sweden.

BACKGROUND. Activated platelets have been implicated in both acute thrombus formation and atherogenesis. Because smoking is a risk factor for cardiovascular disease in men and women and male smokers have biochemical evidence of increased platelet activation, we found it of interest to study whether smoking augments platelet activity in women as well. METHODS AND RESULTS. Data on smoking habits and a urinary sample were obtained from 125 healthy female nonsmokers and an equal number of smokers, stratified by age in five groups from 18 to 59 years old. Urinary samples were analyzed with gas chromatography/mass spectrometry for the 2,3-dinormetabolites of thromboxane A2 (Tx-M), reflecting platelet activity, and prostacyclin (PGI-M), representing platelet/vessel wall interaction. Urinary Tx-M in smokers was higher than in nonsmokers (p < 0.001), increasing with the number of cigarettes smoked per day and with age. In nonsmokers, there was no difference in Tx-M between the age groups. Urinary PGI-M in smokers was higher than that in nonsmokers (p < 0.001) and decreased with age in nonsmokers but not in smokers. There was no difference in Tx-M between previous smokers and lifelong nonsmokers. CONCLUSIONS. The elevated Tx- M in women who smoke cigarettes indicates an increased platelet activity that is dependent on smoking intensity. In parallel, PGI-M is augmented, suggesting that platelet/vessel wall interaction is stimulated. Quitting smoking is an effective means to restore platelet function. We propose that the observed increase in platelet activity in women who smoke cigarettes may be related to subsequent development of cardiovascular disease and that quitting smoking should be considered a high-priority medical target also in this sex.


This article has been cited by other articles:


Home page
CirculationHome page
E. K. Tong and S. A. Glantz
Tobacco Industry Efforts Undermining Evidence Linking Secondhand Smoke With Cardiovascular Disease
Circulation, October 16, 2007; 116(16): 1845 - 1854.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Collins, G. Rosano, C. Casey, C. Daly, M. Gambacciani, P. Hadji, R. Kaaja, T. Mikkola, S. Palacios, R. Preston, et al.
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists
Eur. Heart J., August 2, 2007; 28(16): 2028 - 2040.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. V. Petrik, H. A. Gelabert, W. S. Moore, W. Quinones-Baldrich, and M. M. Law
Cigarette Smoking Accelerates Carotid Artery Intimal Hyperplasia in a Dose-Dependent Manner
Stroke, August 1, 1995; 26(8): 1409 - 1414.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
J. H. Vial and C. Narkowicz
Comparison of Cyclooxygenase Inhibition with Two Different Doses of Enteric Coated Aspirin in Normal Young and Elderly Subjects and Elderly with Cerebrovascular Disease
Clinical and Applied Thrombosis/Hemostasis, January 1, 1995; 1(1): 55 - 61.
[Abstract] [PDF]